AC176

AC176 · Accutar Biotechnology Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AC176, covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer [Phase 1]